Lignans isolated from Campylotropis hirtella (Franch.) Schindl. decreased prostate specific antigen and androgen receptor expression in LNCaP cells

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 16, 2008, Pages 6928-6935

  Han, Hui Ying ^a   Wang, Xiang Hong ^a   Wang, Nai L I ^b   Ling, Ming Tat ^a   Wong, Yong Chuan ^a   Yao, Xin Sheng ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Key Laboratory for Research and Development of Traditional Chinese Medicine and Natural Medicine   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Androgen receptor; Apoptosis; Campylotropis hirtella (Franch.) Schindl; Lignans; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; LIGNAN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; LEGUME; MALE; PLANT ROOT; PROSTATE TUMOR; SECRETION; TUMOR CELL LINE;

CELL LINE, TUMOR; FABACEAE; HUMANS; LIGNANS; MALE; PLANT ROOTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

CAMPYLOTROPIS; HIRTELLA;

EID: 51649120430     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800476r     Document Type: Article

References (34)

1. Stewart, A. B.; Lwaleed, B. A.; Douglas, D. A.; Birch, B. R. Current drug therapy for prostate cancer: an overview. Curr. Med. Chem.: Anti-Cancer Agents 2005, 5, 603-612.
2. Bracarda, S.; de Cobelli, O.; Greco, C.; Prayer-Galetti, T.; Valdagni, R.; Gatta, G.; de Braud, F.; Bartsch, G. Cancer of the prostate. Crit. Rev. Oncol. Hematol. 2005, 56, 379-396.
3. Capodice, J. L.; Katz, A. E. What patients take without telling you: holistic approach for BPH. World J. Urol. 2006, 24, 378-382.
4. Katz, A. E. Flavonoid and botanical approaches to prostate health. J. Altern. Complement Med. 2002, 8, 813-821.
5. Denis, L.; Morton, M. S.; Griffiths, K. Diet and its preventive role in prostatic disease. Eur. Urol. 1999, 35, 377-387.
6. McCann, M. J.; Gill, C. I.; McGlynn, H.; Rowland, I. R. Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr. Cancer 2005, 52, 1-14.
7. Han, H. Y.; Shan, S.; Zhang, X.; Wang, N. L.; Lu, X. P.; Yao, X. S. Down-regulationof prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L. Phytomedicine 2007, 14, 338-343.
8. Lu, X. Z.; Xu, W. B.; Shen, J. X. Chemical studies on Campylotropis hirtella (Franch. Schindl.). Zhongguo Zhongyao Zazhi 1997, 22 (11), 680-682.
9. Qin, L.; Chen, X. M.; Chen, W. X.; Yang, L.; Zhang, C. K. Study on tannins from Campylotropis hirtella. Tianran Chanwu Yanjiu Yu Kaifa 1991, 3, 31-34.
10. Kim, J.; Coetzee, G. A. Prostate specific antigen gene regulation by androgen receptor. J Cell. Biochem. 2004, 93, 233-241.
11. Chatterjee, B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol. Cell. Biochem. 2003, 253, 89-101.
12. Culig, Z.; Hobisch, A.; Hittmair, A.; Peterziel, H.; Cato, A. C.; Bartsch, G.; Klocker, H. Expression, structure and function of androgen receptor in advanced prostatetic carcinoma. Prostate 1998, 35, 63-70.
13. Zegarra-Moro, O. L.; Schmidt, L. J.; Huang, H.; Tindall, D. J. Disruption of androgen receptor function inhibits proliferation of androgenrefractory prostate cancer cells. Cancer Res. 2002, 62, 1008-1013.
14. Butler, L. M.; Centenera, M. M.; Neufing, P. J.; Buchanan, G.; Choong, C. S.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M. P.; Tilley, W. D. Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant. Mol. Endocrinol. 2006, 20, 1009-1024.
15. Liao, X.; Tang, S.; Thrasher, J. B.; Griebling, T. L.; Li, B. Small-interfering RNA induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol. Cancer Ther. 2005, 4, 505-515.
16. Haag, P.; Bektic, J.; Bartsch, G.; Klocker, H.; Eder, I. E. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J. Steroid Biochem. Mol. Biol. 2005, 96, 251-258.
17. Cheung, H. W.; Jin, D. Y.; Ling, M. T.; Wong, Y. C.; Wang, Q.; Tsao, S. W.; Wang, X. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res. 2005, 65, 1450-1458.
18. Yuen, M. S. M.; Xue, F.; Mak, T. C. W.; Wong, H. N. C. On the absolute structure of optically active neolignans containing a dihydrobenzo[b] furan skeleton. Tetrahedron 1998, 54, 12429-12444.
19. Li, S.; Lundquist, K.; Wallis, A. F. A. Revised structure for a neolignan from Brucea jaVanica. Phytochemistry 1998, 49, 2125-2128.
20. Miki, K.; Takehara, T.; Sasaya, T.; Sakakibara, A. Lignans of Larix leptolepis. Phytochemistry 1980, 19, 449-453.
21. Sawabe, A.; Mathubara, Y.; Kumamoto, H.; Iizuka, Y.; Okamoto, K. Structure and physiological activity of phenyl propanoid glycosides of hassaku (Citrus hassaku Hort.) and orange (Citrus sinensis Osbeck.) peels. Nippon Nogei Kagaku Kaishi 1986, 60, 593-599.
22. Fonseca, S. B.; De Paiva Campello, J.; Barata, L. E. S.; Ruveda, E. A. 13C-NMR analysis of lignans from Araucaria augustifolia. Phytochemistry 1978, 17, 499-502.
23. Yoshinari, K.; Sashida, Y.; Shimomura, H. Two new lignan xylosides from the barks of Prunus ssiori and Prunus padus. Chem. Pharm. Bull. 1989, 37, 3301-3303.
24. Suzuki, H.; Ueda, T.; Ichikawa, T.; Ito, H. Androgen receptor involvement in the progression of prostate cancer. Endocr. - Relat. Cancer 2003, 10, 209-216.
25. Chiu, F. L.; Lin, J. K. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate 2008, 68, 61-71.
26. Kelly, W. K.; Scher, H. I.; Mazumdar, M.; Vlamis, V.; Schwartz, M.; Fossa, S. D. Prostate specific antigen as a measure of disease outcome in hormone-refractory prostatic cancer. J. Clin. Oncol. 1993, 11, 607-615.
27. Cohen, P.; Graves, H. C.; Peehl, D. M.; Kamarei, M.; Giudice, L. C.; Rosenfeld, R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 1992, 75, 1046-1053.
28. Mantzoros, C. S.; Tzonou, A.; Signorello, L. B.; Stampfer, M.; Trichopoulos, D.; Adami, H. O. Insulin-like growth factor-1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer 1997, 76, 1115-1118.
29. Chan, J. M.; Stampfer, M. J.; Giovannucci, E.; Gann, P. H.; Ma, J.; Wilkinson, P.; Hennekens, C. H.; Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998, 279, 563-566.
30. Cohen, P.; Peehl, D. M.; Graves, H. C.; Rosenfeld, R. G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol. 1994, 142, 407-415.
31. Potter, J. D. Patterns of diet. In Food, Nuirition, and the Prevention of Cancer: A Global Perspective; American Institute for Cancer Research: Washington, DC, 1997; pp 22-34.
32. Adlercreutz, H.; Mazur, W. Phyto-oestrogens and Western diseases. Ann. Med. 1997, 29, 95-120.
33. Dhom, G. Epidemiology of hormone-depending tumours. In Endocrine Dependent Tumours; Voigt, K., Knabbe, C., eds.; Raven Press: New York, 1991, pp 1-42.
34. Lin, X.; Swtizer, B. R.; Demark-Wahnefried, W. Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 2001, 21, 3995-4000.